Abstract # 1001 Phase 1 TITE-CRM Dose Escalation Study Of Concurrent Temozolomide And Intensity Modulated Radiation Therapy In Newly Diagnosed Glioblastoma Multiforme

Presenter: Doris Brown, MD, PhD


Abstract:


E-mail a friend about this poster:
Enter email address: